Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The Compensation Committee of Revance’s Board of Directors approved the awards as an inducement material to the new employees’ employment in accordance with NASDAQ Listing Rule 5635(c)(4).
About
“Revance Therapeutics” and the Revance logo are registered trademarks of
RHA resilient hyaluronic acid® and RHA® are trademarks of
BOTOX® is a registered trademark of
View source version on businesswire.com: https://www.businesswire.com/news/home/20210119005213/en/
Investors
Jessica.serra@revance.com
or
laurence@gilmartinir.com
Media
sfahy@revance.com
or
General Media:
Goodfuse:
Jenifer Slaw, 347-971-0906
jenifer.slaw@YR.com
or
Trade Media:
Nadine Tosk, 504-453-8344
nadinepr@gmail.com
Source: